May 01, 2013

Lyxumia▼® (lixisenatide) - effective new Type 2 diabetes treatment could save the NHS millions offering value and choice

Guildford, UK - Sanofi Diabetes annunced today the launch of Lyxumia (lixisenatide), the first once daily prandial GLP-1 agonist which has the potential to save the NHS £70 million over the next 5 years.

• Download the Press Release Dated May 1, 2013 (PDF, 438Kb)

March 15, 2013

Sanofi Diabetes announces today £10,000 funding for projects to support optimum diabetes management

Sanofi Diabetes announces today a £10,000 donation to help fund three Diabetes UK initiatives at their annual professional conference in Manchester.

• Download the Press Release Dated March 15, 2013 (PDF, 74Kb)

March 06, 2013

Sanofi Launches 2013 Patient Group Bursary Scheme and Demonstrates Ongoing Commitment to Patient Empowerment

Sanofi has announced the launch of its 2013 Patient Group Bursary Scheme, a much valued initiative which awards a share of £50,000 to three successful Patient Groups that are able to demonstrate ambitious, but realistic campaigns capable of making a lasting difference to the lives of patients in their respective fields.

• Download the Press Release Dated March 06, 2013 (PDF, 120Kb)

March 04, 2013

ZALTRAP▼® (aflibercept) is now available in the UK for the treatment of advanced metastatic colorectal cancer (mCRC)

Sanofi and Regeneron Pharmaceuticals, Inc. announced today that they have launch ZALTRAP (aflibercept) which is licensed for use in combination with irinotecan/5-flourouracil/folinic acid (FOLFIRI) chemotherapy for the treatment of adults with mCRC that is resistant to or has progressed after an oxaliplatin-based regimen.

• Download the Press Release Dated March 04, 2013 (PDF, 139Kb)

March 01, 2013

Sanofi reaches target to raise £100,000 for Teenage Cancer Trust

Employees, friends and families of the Sanofi group across the UK and ireland spent 2012 taking part in a wide range of challenges to raise £100,000 for Teenage Cancer Trust, the only UK charity dedicated to supporting young people with cancer.

• Download the Press Release Dated February 28, 2013 (PDF, 701Kb)

January 08, 2013

Sanofi Provides an Update on its Research & Development Pipeline

Sanofi today will provide an update on its Research & Development (R&D) pipeline with Dr. Elias Zerhouni, President, Global Research and Development, presenting at the JP Morgan Healthcare Conference in San Francisco, California.

• Download the Press Release Dated January 08, 2013 (PDF, 211Kb)